St. Johns Investment Management Company LLC Sells 105 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

St. Johns Investment Management Company LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.0% in the fourth quarter, Holdings Channel reports. The institutional investor owned 2,541 shares of the healthcare conglomerate’s stock after selling 105 shares during the period. St. Johns Investment Management Company LLC’s holdings in UnitedHealth Group were worth $1,285,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Sound Income Strategies LLC grew its stake in shares of UnitedHealth Group by 6.6% in the fourth quarter. Sound Income Strategies LLC now owns 2,069 shares of the healthcare conglomerate’s stock worth $1,047,000 after purchasing an additional 129 shares during the last quarter. LexAurum Advisors LLC lifted its stake in shares of UnitedHealth Group by 4.2% in the fourth quarter. LexAurum Advisors LLC now owns 10,089 shares of the healthcare conglomerate’s stock worth $5,103,000 after acquiring an additional 403 shares during the period. RFG Advisory LLC increased its position in UnitedHealth Group by 3.3% during the 4th quarter. RFG Advisory LLC now owns 4,635 shares of the healthcare conglomerate’s stock valued at $2,344,000 after purchasing an additional 150 shares during the period. Motive Wealth Advisors lifted its position in shares of UnitedHealth Group by 17.1% in the 4th quarter. Motive Wealth Advisors now owns 755 shares of the healthcare conglomerate’s stock worth $382,000 after purchasing an additional 110 shares during the period. Finally, MFA Wealth Services acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $512,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

UNH has been the subject of a number of recent analyst reports. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Barclays cut their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $627.74.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Trading Up 0.5 %

Shares of UNH stock opened at $532.26 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market cap of $489.83 billion, a P/E ratio of 34.34, a PEG ratio of 1.41 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a 50 day moving average of $542.24 and a 200-day moving average of $563.54.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the company earned $5.83 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.58%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.